{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:57:25Z","timestamp":1758405445897},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9177-17","type":"journal-article","created":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T22:09:46Z","timestamp":1508105386000},"page":"59-63","source":"Crossref","is-referenced-by-count":3,"title":["Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest"],"prefix":"10.2169","volume":"57","author":[{"given":"Kosuke","family":"Inoue","sequence":"first","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Saito","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, University of Yamanashi Interdisciplinary Graduate School of Medicine and Engineering, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Miki","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Diabetes, JCHO Tokyo Yamate Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiho","family":"Sugisawa","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Tsurutani","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kowase","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kakuta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Omura","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med 118: 706-714, 2005.","DOI":"10.1016\/j.amjmed.2004.11.028"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 22: 240-254, 2001.","DOI":"10.1210\/edrv.22.2.0427"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95: 2529-2535, 2010.","DOI":"10.1210\/jc.2010-0180"},{"key":"4","unstructured":"4. Uchida T, Kasai T. Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. 2014: 534904, 2014."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mehta AN, Vallera RD, Tate CR, Sager RA, Welch BJ. Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis. Bayl Univ Med Cent 21: 382-385, 2008.","DOI":"10.1080\/08998280.2008.11928432"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hashimoto K, Ota M, Irie T, et al. A case of type 2 amiodarone-induced thyrotoxicosis that underwent total thyroidectomy under high-dose steroid administration. Case Rep Endocrinol 2015: 416145, 2015.","DOI":"10.1155\/2015\/416145"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 80: 99-105, 2005.","DOI":"10.4065\/80.1.99"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Trimboli P, Ruggieri M, Fumarola A, et al. A mathematical formula to estimate <i>in vivo<\/i> thyroid volume from two-dimensional ultrasonography. Thyroid 18: 879-882, 2008.","DOI":"10.1089\/thy.2007.0399"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kennedy RL, Griffiths H, Gray TA. Amiodarone and the thyroid. Clin Chem 35: 1882-1887, 1989.","DOI":"10.1093\/clinchem\/35.9.1882"},{"key":"10","unstructured":"10. Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 35: 340-348, 2012."},{"key":"11","unstructured":"11. Eskes SA, Endert E, Fliers E, et al. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab 97: 499-506, 2012."},{"key":"12","unstructured":"12. Bogazzi F, Tomisti L, Rossi G, et al. Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J Clin Endocrinol Metab 94: 3757-3762, 2009."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bogazzi F, Bartalena L, Tomisti L, et al. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92: 556-562, 2007.","DOI":"10.1210\/jc.2006-2059"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gough J, Gough IR. Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 30: 1957-1961, 2006.","DOI":"10.1007\/s00268-005-0673-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Smyrk TC, Goellner JR, Brennan MD, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 11: 197-204, 1987.","DOI":"10.1097\/00000478-198703000-00004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakazawa T, Murata S, Kondo T, et al. Histopathology of the thyroid in amiodarone-induced hypothyroidism. Pathol Int 58: 55-58, 2008.","DOI":"10.1111\/j.1440-1827.2007.02189.x"},{"key":"17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/thy.2010.0368","volume":"21","author":"T Ando","year":"2011","unstructured":"17. Ando T, Henmi T, Haruta D, et al. Graves&apos; disease complicated by ventricular fibrillation in three men who were smokers. Thyroid 21: 1021-1025, 2011.","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Brooks MJ, Pattison DA, Teo EP, Price S, Gurvitch R. Amiodarone-induced destructive thyroiditis associated with coronary artery vasospasm and recurrent ventricular fibrillation. Eur Thyroid J 2: 65-67, 2013.","DOI":"10.1159\/000345528"},{"key":"19","unstructured":"19. Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 91: 2490-2495, 2006."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Abbasi B, Sharif Z, Sprabery LR. Hypokalemic thyrotoxic periodic paralysis with thyrotoxic psychosis and hypercapnic respiratory failure. Am J Med Sci 340: 147-153, 2010.","DOI":"10.1097\/MAJ.0b013e3181cbf567"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wu CZ, Wu YK, Lin JD, Kuo SW. Thyrotoxic periodic paralysis complicated by acute hypercapnic respiratory failure and ventricular tachycardia. Thyroid 18: 1321-1324, 2008.","DOI":"10.1089\/thy.2008.0232"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_9177-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T22:49:55Z","timestamp":1603147795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_9177-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9177-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}